Please provide your email address to receive an email when new articles are posted on . Three measures of lung function improved between baseline and 12 months. Observed improvements were not as large ...

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...

Peak nasal inspiratory flow (PNIF) measurement was a feasible, noninvasive method for assessing nasal airflow obstruction in children with cystic fibrosis and correlated significantly with nasal ...

BUFFALO, N.Y. — A University at Buffalo psychiatrist who has played a critical role in getting mental health screening and treatment integrated into routine care for adults and adolescents with cystic ...

Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life, presumably even in ...

Please provide your email address to receive an email when new articles are posted on . Food allergy prevalence was lower in those with cystic fibrosis vs. the general pediatric population. The ...

A University at Buffalo psychiatrist who has played a critical role in getting mental health screening and treatment integrated into routine care for adults and adolescents with cystic fibrosis (CF) ...

The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ...

In the US, children with cystic fibrosis (CF) were significantly less likely to develop food allergies than children without CF. However, boys and children not receiving pancreatic enzyme replacement ...